Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ESCC Molecular Subtypes Based on Multidimensional Features of p53 and Their Clinical Significance

NCT07722819 is registered in ClinicalTrials.gov with Ling Zhiqiang as lead sponsor.

NCT NCT07722819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07722819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ESCC Molecular Subtypes Based on Multidimensional Features of p53 and Their Clinical Significance
Lead sponsor
Ling Zhiqiang
Phase
Observational
Overall status
Completed
Start date
April 21, 2026
Completion date
July 13, 2026
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

p53 mutation in esophageal cancer